Improved waitlist and comparable post-transplant outcomes in simultaneous heart-kidney transplantation under the 2018

Yeahwa Hong1, Nicholas R Hess2, Luke A Ziegler2

  • 1Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pa.

Insights

The 2018 heart allocation policy change improved waitlist outcomes for simultaneous heart-kidney transplantation, reducing wait times and increasing transplant rates. Early post-transplant survival remained comparable after the policy update.

Area of Science:

  • Transplantation Medicine
  • Organ Allocation Policy
  • Cardiovascular Surgery

Background:

  • Simultaneous heart-kidney transplantation (SHKT) is a complex procedure for patients with end-stage heart and kidney disease.
  • The 2018 organ allocation policy update aimed to optimize organ distribution and patient outcomes.
  • Evaluating the impact of policy changes on SHKT is crucial for refining allocation strategies.

Purpose of the Study:

  • To assess clinical trends in SHKT before and after the 2018 US heart allocation policy change.
  • To analyze the impact of the policy change on waitlist outcomes and post-transplant survival in SHKT.
  • To determine the risk-adjusted mortality associated with the 2018 allocation system for SHKT.

Main Methods:

  • Retrospective analysis of the United Network for Organ Sharing registry for adult SHKT patients.
  • Comparison of waitlist and post-transplant outcomes before and after the 2018 policy change.
  • Multivariable analyses to evaluate risk-adjusted hazards for waitlist and post-transplant mortality.

Main Results:

  • The 2018 policy change led to increased SHKT rates, shorter waitlist times, and reduced likelihood of de-listing.
  • Post-transplant outcomes, including 90-day, 6-month, and 1-year survival and complication rates, were comparable before and after the policy change.
  • The 2018 allocation system significantly reduced risk-adjusted 1-year waitlist mortality but did not significantly impact 1-year post-transplant mortality.

Conclusions:

  • The 2018 heart allocation policy enhanced SHKT by improving waitlist metrics.
  • Early post-transplant survival following SHKT remained consistent despite the policy modifications.
  • The policy update demonstrated a positive effect on waitlist mortality, highlighting its benefit for patients awaiting dual organ transplants.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
29
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
39